| Emergency department clinical performance of ADVIA Centaur n-terminal prohormone of B-type natriuretic peptide assay WF Peacock, J Snyder, C Brown, YL Liu, CK Cooper, JL Januzzi Clinica Chimica Acta, 119940, 2024 | | 2024 |
| Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy P Gouda, Y Liu, J Butler, S Del Prato, NE Ibrahim, CSP Lam, T Marwick, ... Cardiovascular Diabetology 23 (1), 281, 2024 | | 2024 |
| No Matter the Breakdown, Heart Failure Is Costly: Heart Failure Costs and Cost-Offsets by Subtype LP Cohen, JL Januzzi Heart Failure 12 (8), 1422-1424, 2024 | | 2024 |
| Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM CJ Coats, A Masri, ME Nassif, R Barriales‐Villa, M Arad, N Cardim, ... Journal of the American Heart Association, e035993, 2024 | | 2024 |
| Lipoprotein (a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp (a) Registry A Shiyovich, AN Berman, SA Besser, DW Biery, R Cardoso, S Divakaran, ... Cardiovascular Diabetology 23 (1), 257, 2024 | | 2024 |
| Racial differences in diabetic cardiomyopathy: the ARISE-HF trial J Lopez, Y Liu, J Butler, S Del Prato, JA Ezekowitz, CSP Lam, TH Marwick, ... Journal of the American College of Cardiology 84 (3), 233-243, 2024 | 1 | 2024 |
| Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory V Blumer, JL Januzzi Jr, JA Lindenfeld, SD Solomon, MA Psotka, ... JACC: Heart Failure, 2024 | | 2024 |
| † Utility of AI-QCPA: Results of the Decisions for Treating Coronary Disease are Changed in Patients Evaluated with Quantified Plaque Analysis R Blankstein, A Pursnani, C Rogers, S Mullen, N Ng, S Raible, W Huey, ... Journal of Clinical Lipidology 18 (4), e581, 2024 | | 2024 |
| Associations between lipoprotein (a), oxidized phospholipids, and extracoronary vascular disease TR Bellomo, Y Liu, TC Gilliland, H Miksenas, S Haidermota, M Wong, ... Journal of Lipid Research 65 (7), 2024 | | 2024 |
| Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction JA Udell, MC Petrie, WS Jones, SD Anker, J Harrington, M Mattheus, ... Journal of the American College of Cardiology 83 (23), 2233-2246, 2024 | 5 | 2024 |
| Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial I Makhlin, BG Demissei, R D'Agostino, WG Hundley, C Baleanu-Gogonea, ... Clinical Cancer Research 30 (11), 2370-2376, 2024 | 1 | 2024 |
| Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis C Yokose, G Challener, B Jiang, B Zhou, N McCormick, S Tanikella, ... Seminars in Arthritis and Rheumatism 66, 152441, 2024 | | 2024 |
| Aficamten for symptomatic obstructive hypertrophic cardiomyopathy MS Maron, A Masri, ME Nassif, R Barriales-Villa, M Arad, N Cardim, ... New England Journal of Medicine 390 (20), 1849-1861, 2024 | 17 | 2024 |
| Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp (a) Registry A Shiyovich, AN Berman, SA Besser, DW Biery, G Kaur, S Divakaran, ... Journal of the American Heart Association 13 (10), e034493, 2024 | 1 | 2024 |
| Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial AF Hernandez, JA Udell, WS Jones, SD Anker, MC Petrie, J Harrington, ... Circulation 149 (21), 1627-1638, 2024 | 12 | 2024 |
| The Hidden Cardiovascular Crisis Among Former NFL Athletes: After the HUDDLE JS Guseh, JL Januzzi Jr Journal of the American College of Cardiology 83 (19), 1838-1840, 2024 | 2 | 2024 |
| Diagnostic methods for cardiovascular diseases RF Rhyne, CA Magaret, JE Strobeck, JL Januzzi Jr US Patent 11,977,083, 2024 | | 2024 |
| Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial JL Januzzi Jr, Y Liu, N Sattar, Y Yavin, CA Pollock, J Butler, M Jardine, ... American Heart Journal 271, 38-47, 2024 | | 2024 |
| Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes RE Aaron, T Tian, GA Fleming, DB Sacks, JL Januzzi Jr, R Pop-Busui, ... Journal of Diabetes Science and Technology 18 (3), 733-740, 2024 | | 2024 |
| Isovolumic Contraction Velocity In Heart Failure With Reduced Ejection Fraction And Effect Of Sacubitril/valsartan: The PROVE-HF Study AMS Omar, S Murphy, GM Felker, I Piña, J Butler, Y Liu, R Mohebi, ... Journal of Cardiac Failure 30 (5), 653-665, 2024 | 1 | 2024 |
